Fig. 2
From: Cardiotoxicity of small-molecule kinase inhibitors in cancer therapy
Cardiovascular toxicities of small-molecule kinase inhibitors. The figure shows the cardiotoxicity events induced by small molecule inhibitors, including myocarditis, atrial fibrillation, hypertension, QT interval prolongation, LV dysfunction, pericardial effusion, heart failure, and myocardial infarction or ischemia. We have identified small molecule inhibitors that induce corresponding cardiotoxicity